Results 181 to 190 of about 6,585,062 (339)

Point mutation in a leucine-rich repeat of platelet glycoprotein Ib alpha resulting in the Bernard-Soulier syndrome. [PDF]

open access: bronze, 1993
Jerry Ware   +6 more
openalex   +1 more source

DeNovoGear: de novo indel and point mutation discovery and phasing

open access: yesNature Methods, 2013
Avinash Ramu   +6 more
semanticscholar   +1 more source

Integrative miRNOMe profiling reveals the miR‐195‐5p–CHEK1 axis and its impact on luminal breast cancer outcomes

open access: yesMolecular Oncology, EarlyView.
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková   +14 more
wiley   +1 more source

A single point mutation on FLT3L-Fc protein increases the risk of immunogenicity. [PDF]

open access: yesFront Immunol
Qin D   +21 more
europepmc   +1 more source

Point Mutations and Their Evolutionary Significance

open access: yes
Point Mutations and Their Evolutionary Significance Abstract Point mutations, involving single-nucleotide alterations in DNA sequences, are fundamental drivers of genetic variation and evolution. These mutations can lead to significant phenotypic changes, influence fitness, and shape the evolutionary trajectories of populations. This article explores
openaire   +1 more source

Association of high‐dose radioactive iodine therapy with PPM1D‐mutated clonal hematopoiesis in older individuals

open access: yesMolecular Oncology, EarlyView.
In thyroid cancer patients, high‐dose (≥7.4 GBq) radioactive iodine therapy (RAIT) was associated with a higher prevalence of clonal hematopoiesis (variant allele frequency >2%) in individuals aged ≥50 years (OR = 2.44). In silico analyses showed that truncating PPM1D mutations conferred a selective advantage under these conditions.
Jaeryuk Kim   +11 more
wiley   +1 more source

A FAN1 point mutation associated with accelerated Huntington's disease progression alters its PCNA-mediated assembly on DNA. [PDF]

open access: yesNat Commun
Aretz J   +11 more
europepmc   +1 more source

Point mutation of glycine receptor α1 subunit in the spasmodic mouse affects agonist responses [PDF]

open access: bronze, 1994
Brigitta Saul   +6 more
openalex   +1 more source

Home - About - Disclaimer - Privacy